XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Total revenue $ 9,033 $ 7,427
Cost of sales 6,754 5,685
Gross profit 2,279 1,742
Operating expenses:    
Selling, general and administrative 11,985 6,524
Research and development 4,850 5,046
Change in fair value of contingent earnout   14
Total operating expenses 16,835 11,584
Loss from operations (14,556) (9,842)
Interest and financing costs, net (966) (1,064)
Loss before income tax expense (15,522) (10,906)
Net loss and comprehensive loss $ (15,522) $ (10,906)
Net loss per share attributable to common stock - basic and diluted $ (0.59) $ (9.05)
Weighted-average shares outstanding - basic and diluted 26,405,252 1,205,314
Product    
Total revenue $ 7,203 $ 5,809
Cost of sales 6,078 5,075
Gross profit 1,125 734
Operating expenses:    
Selling, general and administrative 11,526 6,066
Research and development 4,431 4,639
Change in fair value of contingent earnout   14
Total operating expenses 15,957 10,719
Loss from operations (14,832) (9,985)
Software    
Total revenue 1,830 1,618
Cost of sales 676 610
Gross profit 1,154 1,008
Operating expenses:    
Selling, general and administrative 459 458
Research and development 419 407
Total operating expenses 878 865
Loss from operations $ 276 $ 143